Dr. Reddy’s Laboratories has launched generic anti-viral Valganciclovir tablets in the US market. The company has launched Valganciclovir tablets, USP in the strength of 450 mg in the US market yesterday and the product has been approved by the United States Food and Drug Administration ( USFDA) The tablets are generic version of Roche’s Valcyte tablets
Company Profile : Dr Reddys Laboratories Ltd
Leave a Reply